Lv11
18 积分 2025-04-09 加入
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
1小时前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
1小时前
已完结
Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
2天前
已完结
Thirty years of NRF2: advances and therapeutic challenges
10天前
已完结
Trends in target novelty in oncology R&D
11天前
已完结
Breakthrough therapy designations in China and the United States
13天前
已完结
Importing oncology trials from China: a bridge over troubled waters?
1个月前
已完结
Progress in outcomes for patients with metastatic squamous non-small-cell lung cancer
1个月前
已完结
Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
皖公网安备34019202002308
